Evaluation of a Portable Device for Assessing Sleep Disordered Breathing in Congestive Heart Failure

ResMed

Status: Completed

Conditions: Sleep Apnea Syndromes; Heart Failure, Congestive

Treatments: Device: ApneaLink

Study type: Observational

Funder types: Industry

Identifiers

NCT00493948

X06- 0237

Details and patient eligibility

About

The purpose of this study is to evaluate an approved, portable device for assessing Sleep Disordered Breathing in Congestive Heart Failure.

Enrollment: 35 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Moderate to severe heart failure (as determined via Echocardiogram or treating physician)

Exclusion criteria

• Clinically significant asthma requiring therapy
• Significant (parenchymal) lung disease
• Severe pulmonary hypertension
• Hypercapnia (PCO2 > 60mmHg)
• Cardiogenic Shock
• Severe chronic renal failure
• Narcotic abuse/intravenous drug use (including heart failure due to alcohol abuse or chemotherapy, HIV+ and Hepatitis C)
• Methicillin- resistant Staphylococcus aureus infection
• Tracheotomy
• Enrolled in any concurrent study that may confound the results of this study
• Nocturnal positive airway pressure or oxygen
• Inability or refusal to sign patient consent form
• Inability or refusal to adhere to protocol requirements